3-[2-[6-(cyclopropylamino)pyridazin-3-yl]ethynyl]-4-methyl-N-[4-(5-methyl-1H-imidazol-2-yl)-3-(trifluoromethyl)phenyl]benzamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-[2-[6-(cyclopropylamino)pyridazin-3-yl]ethynyl]-4-methyl-N-[4-(5-methyl-1H-imidazol-2-yl)-3-(trifluoromethyl)phenyl]benzamide
• 化学式: C₂₈H₂₃F₃N₆O
• 分子量: 516.5
• InChiKey: LBVCCOJVUKIUEZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  38
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  95.6
• 氢给体数：
  3
• 氢受体数：
  8

文献信息

• PROTEIN KINASE INHIBITORS
  申请人：Astar Biotech LLC

  公开号：EP2880038A1

  公开（公告）日：2015-06-10
• [EN] PROTEIN KINASE INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉINES KINASES
  申请人：ASTAR BIOTECH LLC

  公开号：WO2014019338A1

  公开（公告）日：2014-02-06

  Disclosed are compounds of Formula I, as well as pharmaceutically acceptable salts, hydrates, isomers, or solvates thereof. Also disclosed are pharmaceutical compositions which comprise the compounds of Formula I, and methods for inhibiting protein kinase and methods of treating diseases, such as cancers, inflammation.